ArticleAntimicrobial agents and chemotherapy2009

Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin.

Weerawat Manosuthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.